• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旅行者中的炎症性肠病:选择合适的疫苗和检查。

Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

机构信息

Department of Gastroenterology, Hospital Universitari Mútua de Terrassa, Fundació per la Recerca Mútua de Terrassa, University of Barcelona, Terrassa, Catalonia, 08221, Spain.

出版信息

World J Gastroenterol. 2011 Jun 14;17(22):2708-14. doi: 10.3748/wjg.v17.i22.2708.

DOI:10.3748/wjg.v17.i22.2708
PMID:21734778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3122259/
Abstract

The majority of patients with inflammatory bowel disease (IBD) achieve good control of the inflammatory activity using available therapies. When remission is achieved and quality of life recovered, a considerable proportion of IBD patients express their desire to travel abroad, be it for business, academic or leisure purposes. Their physicians should help and encourage them whenever possible. However, preventive measures are warranted to minimize the risk, since IBD patients are exposed to the same infections affecting the general population, plus opportunistic infections (OI) related to the immunosuppression. There are a large number of potential OI that might affect patients with IBD. The true prevalence of these infections is unknown, and can vary from country to country. Therefore, reactivation or de novo acquisition of infections such as tuberculosis, malaria, and viral hepatitis will be much more frequent in endemic areas. Therefore, physicians should be aware of these aspects when planning specific preventive measures for patients traveling to a particular country. This includes good control of environmental exposure, chemoprophylaxis when indicated, and the use of a specific vaccination program to prevent endemic infections. In addition, it should be noted that, though the risk of acquiring an infectious disease is probably greater for IBD patients traveling from a developed to a developing country, the inverse situation can also occur; it depends on the previous acquired immunity of the host against infections in any particular environment.

摘要

大多数炎症性肠病(IBD)患者使用现有疗法可实现炎症活动的良好控制。当达到缓解且生活质量恢复后,相当一部分 IBD 患者表示希望出国旅行,无论是出于商务、学术还是休闲目的。医生应尽可能为他们提供帮助和鼓励。然而,需要采取预防措施来尽量降低风险,因为 IBD 患者面临与普通人群相同的感染风险,以及与免疫抑制相关的机会性感染(OI)。有大量潜在的 OI 可能影响 IBD 患者。这些感染的真实患病率尚不清楚,并且可能因国家而异。因此,在流行地区,结核病、疟疾和病毒性肝炎等感染的再激活或新发病例会更加频繁。因此,当为前往特定国家旅行的患者制定特定的预防措施时,医生应注意这些方面。这包括良好控制环境暴露、在有指征时进行化学预防以及使用特定的疫苗接种计划来预防地方性感染。此外,应该注意的是,尽管从发达国家前往发展中国家的 IBD 患者获得传染病的风险可能更高,但情况也可能相反;这取决于宿主在任何特定环境中针对感染获得的先前免疫力。

相似文献

1
Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.旅行者中的炎症性肠病:选择合适的疫苗和检查。
World J Gastroenterol. 2011 Jun 14;17(22):2708-14. doi: 10.3748/wjg.v17.i22.2708.
2
Malaria Surveillance - United States, 2016.疟疾监测 - 美国,2016 年。
MMWR Surveill Summ. 2019 May 17;68(5):1-35. doi: 10.15585/mmwr.ss6805a1.
3
Updates on vaccinating the inflammatory bowel disease patient.炎症性肠病患者的疫苗接种最新进展。
Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):229-239. doi: 10.1080/17474124.2019.1565993. Epub 2019 Jan 21.
4
Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.旅行相关疾病监测——GeoSentinel 监测系统,美国,1997-2011 年。
MMWR Surveill Summ. 2013 Jul 19;62:1-23.
5
Compliance of Austrian tourists with prophylactic measures.奥地利游客对预防措施的遵守情况。
Eur J Epidemiol. 1992 Mar;8(2):243-51. doi: 10.1007/BF00144808.
6
Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey.与旅行相关的传染病方面的知识、态度和行为:欧洲机场调查
J Travel Med. 2004 Jan-Feb;11(1):3-8. doi: 10.2310/7060.2004.13609.
7
Travel-associated health risks for patients with inflammatory bowel disease.旅行者相关的健康风险:炎症性肠病患者
Clin Gastroenterol Hepatol. 2012 Feb;10(2):160-5, 165.e1. doi: 10.1016/j.cgh.2011.10.025. Epub 2011 Nov 2.
8
German travelers' preferences for travel vaccines assessed by a discrete choice experiment.德国旅行者对旅行疫苗的偏好通过离散选择实验进行评估。
Vaccine. 2018 Feb 8;36(7):969-978. doi: 10.1016/j.vaccine.2018.01.004. Epub 2018 Jan 12.
9
How do we manage vaccinations in patients with inflammatory bowel disease?我们如何管理炎症性肠病患者的疫苗接种?
Dig Dis. 2009;27(3):370-4. doi: 10.1159/000228576. Epub 2009 Sep 24.
10
Hepatitis A, typhoid and malaria among travelers--surveillance data from Québec (Canada).旅行者中的甲型肝炎、伤寒和疟疾——来自加拿大魁北克的监测数据
J Travel Med. 2006 Jul-Aug;13(4):219-26. doi: 10.1111/j.1708-8305.2006.00031.x.

引用本文的文献

1
Improving immunization strategies in patients with inflammatory bowel disease.改善炎症性肠病患者的免疫接种策略。
Ann Gastroenterol. 2019 May-Jun;32(3):247-256. doi: 10.20524/aog.2019.0351. Epub 2019 Jan 15.
2
Inflammatory Bowel Disease in Travelers.旅行者中的炎症性肠病
Gastroenterol Hepatol (N Y). 2018 Jun;14(6):377-379.
3
Travel health and pretravel preparation in the patient with inflammatory bowel disease.炎症性肠病患者的旅行健康与旅行前准备
Frontline Gastroenterol. 2016 Jan;7(1):60-65. doi: 10.1136/flgastro-2014-100548. Epub 2015 Apr 22.
4
Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?炎症性肠病患者的预防性护理:有哪些新进展?
Dig Dis Sci. 2016 Aug;61(8):2205-2216. doi: 10.1007/s10620-016-4146-x. Epub 2016 Apr 9.
5
Prevention of infection caused by immunosuppressive drugs in gastroenterology.预防胃肠病学中免疫抑制药物引起的感染。
Ther Adv Chronic Dis. 2013 Jul;4(4):167-85. doi: 10.1177/2040622313485275.
6
Vaccines and recommendations for their use in inflammatory bowel disease.疫苗及其在炎症性肠病中的应用建议。
World J Gastroenterol. 2013 Mar 7;19(9):1354-8. doi: 10.3748/wjg.v19.i9.1354.
7
Efficacy of the vaccination in inflammatory bowel disease.疫苗接种在炎症性肠病中的疗效。
World J Gastroenterol. 2013 Mar 7;19(9):1349-53. doi: 10.3748/wjg.v19.i9.1349.

本文引用的文献

1
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.欧洲关于炎症性肠病机会性感染预防、诊断和管理的循证共识
J Crohns Colitis. 2009 Jun;3(2):47-91. doi: 10.1016/j.crohns.2009.02.010. Epub 2009 Apr 26.
2
Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents.T细胞干扰素-γ释放试验在预防接受抗TNF药物治疗的免疫抑制患者潜伏性结核感染再激活中的作用。
J Crohns Colitis. 2008 Sep;2(3):250-4. doi: 10.1016/j.crohns.2008.05.007. Epub 2008 Jul 7.
3
World Influenza Congress Europe 2009.世界流感大会欧洲 2009 年会议
Expert Rev Vaccines. 2010 Mar;9(3):273-5. doi: 10.1586/erv.10.10.
4
Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.四价脑膜炎球菌疫苗:在选择使用结合疫苗还是多糖疫苗时,低反应性是一个重要的考虑因素。
Travel Med Infect Dis. 2010 Jan;8(1):47-50. doi: 10.1016/j.tmaid.2009.12.001. Epub 2010 Jan 8.
5
Diagnosis, management and treatment of chronic Chagas' gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic.克氏锥虫感染非地方性流行地区慢性恰加斯病的诊断、管理与治疗
Gastroenterol Hepatol. 2010 Mar;33(3):191-200. doi: 10.1016/j.gastrohep.2009.07.009. Epub 2009 Oct 17.
6
Strongyloidiasis in transplant patients.移植患者中的类圆线虫病。
Clin Infect Dis. 2009 Nov 1;49(9):1411-23. doi: 10.1086/630201.
7
How do we manage vaccinations in patients with inflammatory bowel disease?我们如何管理炎症性肠病患者的疫苗接种?
Dig Dis. 2009;27(3):370-4. doi: 10.1159/000228576. Epub 2009 Sep 24.
8
Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.免疫抑制会损害炎症性肠病患者对肺炎球菌多糖疫苗的反应。
Am J Gastroenterol. 2010 Jan;105(1):148-54. doi: 10.1038/ajg.2009.523. Epub 2009 Sep 15.
9
Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management.在英国就诊的归国旅行者发热:调查与初始管理建议
J Infect. 2009 Jul;59(1):1-18. doi: 10.1016/j.jinf.2009.05.005. Epub 2009 May 27.
10
Japanese encephalitis in travelers: review of cases and seasonal risk.旅行者中的日本脑炎:病例回顾与季节性风险
J Travel Med. 2009 May-Jun;16(3):217-9. doi: 10.1111/j.1708-8305.2009.00333.x.